These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent. Lewis SJ; Mueller BA Semin Dial; 2014; 27(5):441-5. PubMed ID: 25204875 [TBL] [Abstract][Full Text] [Related]
25. [Adequate anti-infective treatment : Importance of individual dosing and application]. Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208 [TBL] [Abstract][Full Text] [Related]
26. A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients. Heffernan AJ; Mohd Sazlly Lim S; Lipman J; Roberts JA Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100970. PubMed ID: 34728411 [TBL] [Abstract][Full Text] [Related]
27. Antibiotic dosing in multiple organ dysfunction syndrome. Ulldemolins M; Roberts JA; Lipman J; Rello J Chest; 2011 May; 139(5):1210-1220. PubMed ID: 21540219 [TBL] [Abstract][Full Text] [Related]
28. [An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies]. Petejová N; Martínek A; Zahálková J; Duricová J; Plášek J; Valkovský I; Grundmann M; Kacířová I Vnitr Lek; 2012 Jun; 58(6):448-54. PubMed ID: 22913237 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic issues for antibiotics in the critically ill patient. Roberts JA; Lipman J Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886 [TBL] [Abstract][Full Text] [Related]
30. Sepsis and septic shock: selection of empiric antimicrobial therapy. Cunha BA Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948 [TBL] [Abstract][Full Text] [Related]
31. Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial. Roggeveen LF; Guo T; Fleuren LM; Driessen R; Thoral P; van Hest RM; Mathot RAA; Swart EL; de Grooth HJ; van den Bogaard B; Girbes ARJ; Bosman RJ; Elbers PWG Crit Care; 2022 Sep; 26(1):265. PubMed ID: 36064438 [TBL] [Abstract][Full Text] [Related]
32. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients. Hites M; Dell'Anna AM; Scolletta S; Taccone FS Adv Drug Deliv Rev; 2014 Nov; 77():12-21. PubMed ID: 24842474 [TBL] [Abstract][Full Text] [Related]
33. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients? Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944 [TBL] [Abstract][Full Text] [Related]
34. The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients. Fiore M; Peluso L; Taccone FS; Hites M Expert Opin Drug Metab Toxicol; 2021 May; 17(5):543-554. PubMed ID: 33733979 [No Abstract] [Full Text] [Related]
35. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? Pea F; Viale P Crit Care; 2009; 13(3):214. PubMed ID: 19519961 [TBL] [Abstract][Full Text] [Related]
36. We Underdose Antibiotics in Patients on CRRT. Shaw AR; Chaijamorn W; Mueller BA Semin Dial; 2016 Jul; 29(4):278-80. PubMed ID: 27082510 [TBL] [Abstract][Full Text] [Related]
37. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA; Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203 [TBL] [Abstract][Full Text] [Related]
38. Physiological changes in the critically ill patient with sepsis. Hosein S; Udy AA; Lipman J Curr Pharm Biotechnol; 2011 Dec; 12(12):1991-5. PubMed ID: 21554219 [TBL] [Abstract][Full Text] [Related]
39. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? Blot S; Lipman J; Roberts DM; Roberts JA Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849 [TBL] [Abstract][Full Text] [Related]
40. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. Boyer A; Gruson D; Bouchet S; Clouzeau B; Hoang-Nam B; Vargas F; Gilles H; Molimard M; Rogues AM; Moore N Drug Saf; 2013 Apr; 36(4):217-30. PubMed ID: 23508544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]